Geoffrey M. Parker Insider Trading Transactions
Get free email notifications about insider trading for Geoffrey M. Parker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Geoffrey M. Parker. Geoffrey M. Parker is Director in GENOMIC HEALTH INC ($GHDX) and Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and Director in GENOPTIX INC ($GXDX) and Executive Vice President & CFO in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in ChemoCentryx, Inc. ($CCXI) and Director in PERRIGO Co plc ($PRGO) and CFO and EVP in Tricida, Inc. ($TCDA) and Chief Fin. Officer and EVP in Tricida, Inc. ($TCDA) and Chief Fin. Officer and Sr. VP in Tricida, Inc. ($TCDA).
Latest Insider Trading Transactions of Geoffrey M. Parker
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, CCXI, GHDX, GXDX, PRGO, TCDA, SNSS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 5,804 | 0 | 0 | |
May 11 2021 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Payment of Exercise | F | 42.96 | 2,786 | 119,687 | 11,459 | 14.2 K to 11.5 K (-19.56 %) |
May 11 2021 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | M | 42.96 | 5,804 | 249,340 | 14,245 | 8.4 K to 14.2 K (+68.76 %) |
Mar 18 2021 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | P | 41.29 | 2,500 | 103,218 | 2,650 | 150 to 2.7 K (+1,666.67 %) |
Mar 18 2021 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | P | 41.29 | 2,500 | 103,218 | 2,650 | 150 to 2.7 K (+1,666.67 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 55.89 | 13,330 | 744,974 | 12,690 | 26 K to 12.7 K (-51.23 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 56.78 | 16,670 | 946,494 | 26,020 | 42.7 K to 26 K (-39.05 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 60.20 | 1,910 | 114,980 | 42,690 | 44.6 K to 42.7 K (-4.28 %) |
Jan 20 2021 | TCDA | Tricida, Inc. | Parker Geoffrey M. | CFO and EVP | Option Exercise | A | 7.03 | 216,000 | 1,518,480 | 216,000 | |
Dec 10 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | CFO and EVP | Buy | P | 6.78 | 15,000 | 101,700 | 40,000 | 25 K to 40 K (+60.00 %) |
Sep 14 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Grant | A | 0.00 | 4,000 | 0 | 60,837 | 56.8 K to 60.8 K (+7.04 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 7,724 | 0 | 111,913 | 104.2 K to 111.9 K (+7.41 %) |
May 19 2020 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 6,054 | 0 | 0 | |
May 19 2020 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Payment of Exercise | F | 52.76 | 2,906 | 153,321 | 8,441 | 11.3 K to 8.4 K (-25.61 %) |
May 19 2020 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | M | 52.76 | 6,054 | 319,409 | 11,347 | 5.3 K to 11.3 K (+114.38 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 31.66 | 1,439 | 45,559 | 95,000 | 93.6 K to 95 K (+1.54 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 30.09 | 1,303 | 39,207 | 93,561 | 92.3 K to 93.6 K (+1.41 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 30.36 | 19,854 | 602,767 | 92,258 | 72.4 K to 92.3 K (+27.42 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 29.48 | 12,404 | 365,670 | 72,404 | 60 K to 72.4 K (+20.67 %) |
May 11 2020 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 5,804 | 0 | 5,804 | |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 38.21 | 860 | 32,863 | 49,600 | 50.5 K to 49.6 K (-1.70 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 37.40 | 13,959 | 522,008 | 50,460 | 64.4 K to 50.5 K (-21.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 36.72 | 9,181 | 337,100 | 64,419 | 73.6 K to 64.4 K (-12.47 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 35.32 | 2,801 | 98,932 | 73,600 | 76.4 K to 73.6 K (-3.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 34.43 | 3,199 | 110,147 | 76,401 | 79.6 K to 76.4 K (-4.02 %) |
Mar 11 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 29.46 | 5,000 | 147,300 | 55,000 | 50 K to 55 K (+10.00 %) |
Feb 26 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Option Exercise | A | 35.12 | 130,000 | 4,565,600 | 130,000 | |
Dec 04 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 6.00 | 31,990 | 191,940 | 0 | |
Dec 04 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 6.00 | 31,990 | 191,940 | 104,189 | 72.2 K to 104.2 K (+44.31 %) |
Nov 19 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 34.72 | 945 | 32,810 | 50,000 | 49.1 K to 50 K (+1.93 %) |
Nov 19 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 34.28 | 19,055 | 653,205 | 49,055 | 30 K to 49.1 K (+63.52 %) |
Nov 19 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 34.72 | 945 | 32,810 | 50,000 | 49.1 K to 50 K (+1.93 %) |
Nov 19 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 34.28 | 19,055 | 653,205 | 49,055 | 30 K to 49.1 K (+63.52 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 52.41 | 6,583 | 345,015 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 51.72 | 10,000 | 517,200 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 31.53 | 10,000 | 315,300 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 52.41 | 6,583 | 345,015 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 26.07 | 20,000 | 521,400 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 51.72 | 10,000 | 517,200 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Grant | A | 0.00 | 955 | 0 | 0 | 955 to 0 (-100.00 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 31.53 | 10,000 | 315,300 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | D | 26.07 | 20,000 | 521,400 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Grant | A | 0.00 | 955 | 0 | 0 | 955 to 0 (-100.00 %) |
Sep 04 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Option Exercise | M | 1.84 | 54,347 | 99,998 | 196,909 | |
Sep 04 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | M | 1.84 | 54,347 | 99,998 | 56,122 | 1.8 K to 56.1 K (+3,061.80 %) |
Aug 23 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Option Exercise | A | 34.27 | 30,000 | 1,028,100 | 30,000 | |
Aug 14 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 33.60 | 4,531 | 152,242 | 30,000 | 25.5 K to 30 K (+17.79 %) |
Aug 14 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 32.91 | 7,416 | 244,061 | 25,469 | 18.1 K to 25.5 K (+41.08 %) |
Aug 14 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 32.56 | 2,577 | 83,907 | 18,053 | 15.5 K to 18.1 K (+16.65 %) |
Aug 14 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 31.64 | 15,476 | 489,661 | 15,476 | 0 to 15.5 K |
Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 52.41 | 6,583 | 345,015 | 6,583 | |
Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Grant | A | 0.00 | 955 | 0 | 955 | 0 to 955 |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 6.00 | 18,010 | 108,060 | 31,990 | |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 12.00 | 12,815 | 153,806 | 72,199 | 85 K to 72.2 K (-15.07 %) |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 6.00 | 18,010 | 108,060 | 85,014 | 67 K to 85 K (+26.88 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 7,724 | 0 | 7,724 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 8,421 | 0 | 67,004 | 58.6 K to 67 K (+14.37 %) |
May 17 2019 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 3,971 | 0 | 0 | |
May 17 2019 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 6,054 | 0 | 6,054 | |
May 17 2019 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Payment of Exercise | F | 49.55 | 1,907 | 94,492 | 5,293 | 7.2 K to 5.3 K (-26.49 %) |
May 17 2019 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | M | 49.55 | 3,971 | 196,763 | 7,200 | 3.2 K to 7.2 K (+122.98 %) |
Apr 08 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Grant | A | 36.00 | 20,000 | 720,000 | 25,000 | 5 K to 25 K (+400.00 %) |
Nov 13 2018 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 29.72 | 5,000 | 148,600 | 65,000 | 60 K to 65 K (+8.33 %) |
Nov 13 2018 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | P | 65.35 | 3,000 | 196,058 | 5,500 | 2.5 K to 5.5 K (+120.00 %) |
Jul 02 2018 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 19.00 | 60,000 | 1,140,000 | 60,000 | 0 to 60 K |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 08 2018 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 4,265 | 0 | 0 | |
Jun 08 2018 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Payment of Exercise | F | 73.22 | 2,048 | 149,955 | 3,229 | 5.3 K to 3.2 K (-38.81 %) |
Jun 08 2018 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | M | 73.22 | 4,265 | 312,283 | 5,277 | 1 K to 5.3 K (+421.44 %) |
May 30 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 12,912 | 0 | 0 | |
May 30 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 12,912 | 0 | 58,583 | 45.7 K to 58.6 K (+28.27 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
Jul 24 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 511 | 0 | 0 | |
Jul 24 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 1,437 | 0 | 0 | |
Jul 24 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Payment of Exercise | F | 75.51 | 246 | 18,575 | 1,012 | 1.3 K to 1 K (-19.55 %) |
Jul 24 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | M | 75.51 | 511 | 38,586 | 1,258 | 747 to 1.3 K (+68.41 %) |
Jul 24 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Payment of Exercise | F | 75.51 | 690 | 52,102 | 747 | 1.4 K to 747 (-48.02 %) |
Jul 24 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | M | 75.51 | 1,437 | 108,508 | 1,437 | 0 to 1.4 K |
Jun 20 2017 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 31.53 | 10,000 | 315,300 | 10,000 | |
Jun 08 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 1,437 | 0 | 1,437 | |
Jun 08 2017 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 4,265 | 0 | 4,265 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 12,912 | 0 | 12,912 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 20,362 | 0 | 45,671 | 25.3 K to 45.7 K (+80.45 %) |
Dec 12 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 3.90 | 594 | 2,318 | 65,745 | 65.2 K to 65.7 K (+0.91 %) |
Dec 12 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 3.87 | 3,146 | 12,159 | 65,151 | 62 K to 65.2 K (+5.07 %) |
Nov 21 2016 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Buy | P | 88.75 | 2,500 | 221,875 | 2,500 | 0 to 2.5 K |
Nov 18 2016 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 511 | 0 | 511 | |
Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 26.07 | 20,000 | 521,400 | 20,000 | |
May 27 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
May 27 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 0.47 | 9,500 | 4,455 | 62,005 | 52.5 K to 62 K (+18.09 %) |
May 26 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 0.49 | 22,505 | 10,933 | 52,505 | 30 K to 52.5 K (+75.02 %) |
May 26 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 0.46 | 30,000 | 13,881 | 30,000 | 0 to 30 K |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 11,795 | 0 | 25,309 | 13.5 K to 25.3 K (+87.28 %) |
May 13 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 4.03 | 40,000 | 161,388 | 99,600 | 59.6 K to 99.6 K (+67.11 %) |
Apr 01 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Option Exercise | A | 0.54 | 75,000 | 40,500 | 75,000 | |
Jan 11 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 4.63 | 20,000 | 92,512 | 59,600 | 39.6 K to 59.6 K (+50.51 %) |
Dec 14 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 7.30 | 4,621 | 33,724 | 39,600 | 35 K to 39.6 K (+13.21 %) |
Dec 14 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 7.23 | 15,379 | 111,202 | 34,979 | 19.6 K to 35 K (+78.46 %) |
May 29 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 7.51 | 13,513 | 101,515 | 13,514 | 27 K to 13.5 K (-50.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
Mar 23 2015 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Buy | P | 52.43 | 3,000 | 157,304 | 173,000 | 170 K to 173 K (+1.76 %) |
Mar 01 2011 | GXDX | GENOPTIX INC | Parker Geoffrey M. | Director | Sell | U | 25.00 | 501 | 12,525 | 4,167 | 4.7 K to 4.2 K (-10.73 %) |
Dec 03 2010 | GXDX | GENOPTIX INC | Parker Geoffrey M. | Director | Sell | D | 16.93 | 166 | 2,810 | 4,668 | 4.8 K to 4.7 K (-3.43 %) |
Sep 03 2010 | GXDX | GENOPTIX INC | Parker Geoffrey M. | Director | Sell | D | 17.70 | 166 | 2,938 | 4,834 | 5 K to 4.8 K (-3.32 %) |
Jun 03 2010 | GXDX | GENOPTIX INC | Parker Geoffrey M. | Director | Option Exercise | A | 25.17 | 10,000 | 251,700 | 10,000 | |
Jun 03 2010 | GXDX | GENOPTIX INC | Parker Geoffrey M. | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Page: 1